Nasdaq surges toward all-time high as TSM earnings ignite chip stock rally. Trump eases Iran concerns, lifting major uncertainty weighing on US indices.
Source: https://www.fxempire.com/forecasts/article/nasdaq-index-tech…
DraftKings’ bulls were thrown an unexpected curveball, but this new competition doesn’t carry the same brand-name cache. After years of development, Recursion Pharmaceuticals’ AI-powered drug discovery technology should finally, firmly start proving its true value.
Borrowing costs eat into trading profits. These stocks are less expensive to short.
The FOMC held the line on the federal funds rate this week, the first pause after three straight reductions. The Fed is not expected to lower rates again until June, at least according to one survey.
